- Large and growing TAM with industry tailwinds like digitalization supporting growth in demand for OptimizeRx's solutions.
- Highly scalable operating model with more than sufficient network capacity to facilitate growth in the near term.
- OptimizeRx has a strong network of large customers that provides a differentiating factor and competitive advantage to compete against other competitors in the space.
- The company has a solid balance sheet and has been growing revenue at a rapid pace, setting the stage for near term inflection in profitability.
- I initiate OptimizeRx with a price target of $48.50, implying 74% upside from current levels.
For further details see:
OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In Profitability